Gamma Medica to show upgrades at RSNA 2013

By staff writers
November 13, 2013

Molecular imaging developer Gamma Medica plans to unveil new enhancements to its LumaGem molecular breast imaging (MBI) system at RSNA 2013.

The system's redesigned collimator is intended to increase sensitivity, accelerate image acquisition, and decrease procedural time. In addition, an enhanced breast compression system is designed to maximize patient stability and ensure image quality.

Gamma Medica opens doors on new HQ, factory
Molecular imaging developer Gamma Medica has opened the doors on a new corporate headquarters and manufacturing facility.
Gamma Medica wraps up financing
Gamma Medica said it has closed on a $16 million series A financing round from healthcare investment firm Psilos Group Managers.
Gamma Medica's preclinical unit transforms into Trifoil Imaging
The former preclinical division of Gamma Medica formally launched on Wednesday under the new banner of Trifoil Imaging, following its acquisition by investment...
Bankruptcy judge finalizes sale of Gamma Medica business units
Gamma Medica has completed its Chapter 11 bankruptcy process with the separate sales of its molecular breast imaging and preclinical imaging business...
Gamma Medica debuts LumaGuide biopsy device at RSNA
Gamma Medica has added the LumaGuide breast biopsy package to its LumaGem molecular breast imaging (MBI) system, and is showing it as a work-in-progress...

Copyright © 2013

Last Updated np 10/22/2014 10:03:19 AM